Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
October 26, 2021 at 07:19 am EDT
Share
Dr. Lal PathLabs Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 4,984 million compared to INR 4,319 million a year ago. Revenue was INR 5,127 million compared to INR 4,448 million a year ago. Net income was INR 950 million compared to INR 853 million a year ago. Basic earnings per share from continuing operations was INR 11.49 compared to INR 10.34 a year ago. Diluted earnings per share from continuing operations was INR 11.45 compared to INR 10.31 a year ago.
For the six months, sales was INR 11,050 million compared to INR 6,979 million a year ago. Revenue was INR 11,334 million compared to INR 7,222 million a year ago. Net income was INR 2,262 million compared to INR 1,137 million a year ago. Basic earnings per share from continuing operations was INR 27.38 compared to INR 13.79 a year ago. Diluted earnings per share from continuing operations was INR 27.27 compared to INR 13.75 a year ago.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
